Update in the Relationship between Gut Microbiota and Kawasaki Disease
International Journal of TROPICAL DISEASE & Health,
Page 27-31
DOI:
10.9734/ijtdh/2022/v43i1230630
Abstract
Kawasaki disease (KD) is an acute febrile systemic necrotizing medium and small vasculitis in children, mainly affecting children under 5 years old, and has become the main cause of pediatric acquired heart disease in developing countries. The exact etiology of this disease is still unclear. At present, researcheson KD are mostly limited to susceptibility gene, infection and immunity. How ever, there are few studies on the correlation between intestinal flora and KD. In recent years, some studies have found that KD is related to the imbalance of intestinal flora, and the abundance and structure of intestinal flora in children with KD change, which contributes to the occurrence and development of KD by affecting the release of inflammatory factors, damaging the intestinal barrier function and activating the autoimmune system. This review aims to elucidate the relationship between gut microflora and KD, and the mechanism of action and that of probiotics
Keywords:
- Intestinal flora
- mechanism of action of Kawasaki disease
- probiotics
How to Cite
References
Guo MH, Tseng WN, Ko CH, et al. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease [J]. Allergy. 2015;70(3).
Greco A, De Virgilio A, Rizzo MI et al. Kawasaki disease: An evolving paradigm[J]. Autoimmunity Reviews. 2015; 14(8):703-709.
D Yim, Curtis N, Cheung M, et al. Update on Kawasaki disease: Epidemiology, aetiology and pathogenesis [J]. Journal of Paediatrics & Child Health. 2013;49(9): 704-708.
Khan I, Li X A, Law B, et al. Correlation of gut microbial compositions to the development of Kawasaki disease vasculitis in children [J]. Future Microbiology. 2020;15(3).
Wang H, Gong J, Wang W, et al. Are There Any Different Effects of Bifidobacterium, Lactobacillus and Streptococcus on Intestinal Sensation, Barrier Function and Intestinal Immunity in PI-IBS Mouse Model? [J]. Plos One. 2014;9.
Jangid A , Fukuda S , Seki M , et al. Association of colitis with gut-microbiota dysbiosis in clathrin adapter AP-1B knockout mice[J]. Plos One. 2020;15(3): e0228358.
Shimizu J, Kubota T, Takada E, et al. Relative abundance of Megamonas hypermegale and Butyrivibrio species decreased in the intestine and its possible association with the T cell aberration by metabolite alteration in patients with Behcet's disease (210 characters)[J]. Clinical Rheumatology. 2019;38(5):1437-1445.
Shimizu J, Kubota T, Takada E, et al. Bifidobacteria Abundance-Featured Gut Microbiota Compositional Change in Patients with Behcet's Disease[J]. Plos One. 2016;11(4):e0153746.
Shen Nan, Wang Ying, Wang Xingcui, et al. Effect of Kawasaki disease on intestinal microflora in children [J]. Basic Medicine and Clinical Medicine. 2019;39 (5):5.
Chen J, Yue Y, Wang L, et al. Altered gut microbiota correlated with systemic inflammation in children with Kawasaki disease[J]. Scientific Reports. 2020;10(1): 14525.
Akiko, Kinumaki, Tsuyoshi, et al. Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis [J]. Frontiers in Microbiology. 2015;6:824.
Esposito S, Polinori I, Rigante D. The Gut Microbiota-Host Partnership as a Potential Driver of Kawasaki Syndrome [J]. Frontiers in Pediatrics. 2019;7.
Fukazawa M, Fukazawa M, Nanishi E, et al. Previous antibiotic use and the development of Kawasaki disease: A matched pair case-control study [J]. Pediatrics International. 2020;62(9).
Shen J, Ding Y, Yang Z, et al. Effects of changes on gut microbiota in children with acute Kawasaki disease[J]. PeerJ. 2020; 8(1):e9698.
Xuan Miaoyan, Xu Zhen. Association of intestinal microbiota changes in pediatric Kawasaki disease with the level of the specific transcription factors ROR t, FOXP3, and T lymphocyte subsets.
Kaneko K, Akagawa S, Akagawa Y, et al. Our Evolving Understanding of Kawasaki Disease Pathogenesis: Role of the Gut Microbiota [J]. Frontiers in Immunology. 2020;11.
LIU W，LUO X，TANG J，et al. A bridge for short-chain fatty acids to affect inflammatory bowel disease，type 1 diabetes，and nonalcoholic fatty liver disease positively：By changing gut barrier [J]. European Journal of Nutrition. 2021; 60(5):2317-2330.
Wanping A, Shinji Fukuda, et al. Protective effects of bifidobacteria against enteropathogens [J]. Microb Biotechnol. 2019:1–4.
Nana Nie, Cui Bai, Shanai Song, et al. Bifidobacterium plays a protective role in TNF α induced inflammatory response in Caco 2 cell through NF κB and p38MAPK pathways [J]. Molecular and Cellular Biochemistry; 2019.
Qian Fanyu, Zhang Qihao, Cen Jianke, et al. The isms of oligosaccharides improves coronary artery injury in mice with Kawasaki disease by adjusting intestinal microbiota [J]. Journal of Wenzhou Medical University. 2021;51(6):6.
-
Abstract View: 55 times
PDF Download: 21 times
